Four startups make best pitch at Sudbury investor event.

AuthorMigneault, Jonathan
PositionNEWS

Don Duval stood tall and proud when he introduced the first of four startup companies to a Sudbury crowd of potential angel investors and community leaders.

The NORCAT CEO was eager to show off what he calls Sudbury's "exceptional entrepreneurial spirit" at a May 8 inaugural event for angel investors in attendance that was part Dragons' Den and part business incubator in action.

Four startups each had 10 minutes to prove they were worthy of hundreds of thousands of dollars in investment.

"Sudbury Pitch is really formulated around the concept that many of these early-stage companies are great equity plays. Meaning there is a lot of high net worth individuals in the community that can write big cheques. These companies have great valuations," Duval said.

One company, Leak Prevention Ltd., devised an early warning system for pipeline operators to stop leaks before they happen.

The company's patented technology coats pipelines with a special paint that blocks a weak electrical current. The smallest puncture exposes the metal below, which transforms the pipeline into a thousand-kilometre long came of Operation.

But instead of a loud buzzing sound, and the board game patient's nose lighting bright red, the operator is alerted in realtime where the paint may have been nicked. They can then choose to take corrective measures and avoid a spill that would be costly to both the environment and their pocketbooks.

Sudbury entrepreneur Jeff Fuller, company chair, told three panellists he would bring the expertise he has developed in the mining sector, through his mining supply company Fuller Industrial, to the oil and gas sector.

Another company, Very, developed an inexpensive point-of-care filtration system to separate plasma from blood, typically done in a lab centrifuge.

CEO Jeff Sutton's company has developed a material with "fantastic" filtration capabilities that does the same job as a centrifuge for a small fraction of the cost. Pending approval from Health Canada, and the U.S. Food and Drug Administration, patients could potentially buy them with approval from their doctors.

Sutton asked the angel investors in the room for a $650,000 investment to finish development and market themselves to large medical device manufacturers. His plan is to license the device to those manufacturers and make money on royalties.

"The market for point-of-care testing is $50 billion a year,"...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT